Abstract
Several Chrysobalanaceae family members are considered medicinal plants in South America and their infusions have been widely used to treat several diseases, such as diabetes and hypertension. Methanolic extract from the leaves of Licania pittieri (Chrysobalanaceae), has previously shown hypotensive effect in anaesthetized normotensive rats. The aim of this study was to identify the compounds present in the methanolic extract of L. pittieri that could be responsible for the hypotensive effect. Bioactivity-guided fractionation of this extract was done by monitoring the changes induced on mean arterial blood pressure and heart rate on normotensive rats, which led to the isolation of three known compounds identified by NMR spectroscopy methods as pomolic acid, quercetin and astilbin. Pomolic acid (0.4 mg/kg, i.v.) diminished mean arterial blood pressure (24.1 %) for more than 45 minutes and also heart rate (38.7 %), while quercetin and astilbin (4 mg/Kg each, i.v.) showed a weak and transient hypotensive effect. In addition, the observation of nose bleeding in pomolic acid-treated rats led us to investigate its effects on hemostasis. Pomolic acid proved to be a potent inhibitor of the aggregation of human platelets induced by ADP and Epinephrine, exhibited IC50 values close to 60 nM and 20 nM, respectively. In contrast, pomolic acid did not inhibit human platelet aggregation induced by PAF, collagen, U46619 (thromboxane analogue), TRAP or arachidonic acid. These results showed for the first time the hypotensive and platelet anti-aggregating effects of pomolic acid and suggested its potential role in cardiovascular therapy.
Keywords: Licania pittieri, triterpenoids, pomolic acid, flavonoids, cardiovascular screening, platelets
Current Bioactive Compounds
Title: Pomolic Acid Isolated from the Leaves of Licania pittieri Inhibits ADP-and Epinephrine-Induced Platelet Aggregation and has Hypotensive Effect on Rats
Volume: 5 Issue: 3
Author(s): O. Estrada, C. Alvarado-Castillo, A. Z. Fernandez, M. Lopez, E. Romero-Vecchione, J. Vasquez, J. Mendez, D. Conde and A. Cardozo
Affiliation:
Keywords: Licania pittieri, triterpenoids, pomolic acid, flavonoids, cardiovascular screening, platelets
Abstract: Several Chrysobalanaceae family members are considered medicinal plants in South America and their infusions have been widely used to treat several diseases, such as diabetes and hypertension. Methanolic extract from the leaves of Licania pittieri (Chrysobalanaceae), has previously shown hypotensive effect in anaesthetized normotensive rats. The aim of this study was to identify the compounds present in the methanolic extract of L. pittieri that could be responsible for the hypotensive effect. Bioactivity-guided fractionation of this extract was done by monitoring the changes induced on mean arterial blood pressure and heart rate on normotensive rats, which led to the isolation of three known compounds identified by NMR spectroscopy methods as pomolic acid, quercetin and astilbin. Pomolic acid (0.4 mg/kg, i.v.) diminished mean arterial blood pressure (24.1 %) for more than 45 minutes and also heart rate (38.7 %), while quercetin and astilbin (4 mg/Kg each, i.v.) showed a weak and transient hypotensive effect. In addition, the observation of nose bleeding in pomolic acid-treated rats led us to investigate its effects on hemostasis. Pomolic acid proved to be a potent inhibitor of the aggregation of human platelets induced by ADP and Epinephrine, exhibited IC50 values close to 60 nM and 20 nM, respectively. In contrast, pomolic acid did not inhibit human platelet aggregation induced by PAF, collagen, U46619 (thromboxane analogue), TRAP or arachidonic acid. These results showed for the first time the hypotensive and platelet anti-aggregating effects of pomolic acid and suggested its potential role in cardiovascular therapy.
Export Options
About this article
Cite this article as:
Estrada O., Alvarado-Castillo C., Fernandez Z. A., Lopez M., Romero-Vecchione E., Vasquez J., Mendez J., Conde D. and Cardozo A., Pomolic Acid Isolated from the Leaves of Licania pittieri Inhibits ADP-and Epinephrine-Induced Platelet Aggregation and has Hypotensive Effect on Rats, Current Bioactive Compounds 2009; 5 (3) . https://dx.doi.org/10.2174/157340709789054786
DOI https://dx.doi.org/10.2174/157340709789054786 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
Call for Papers in Thematic Issues
Antioxidants: Unveiling their Power in Health and Disease
Antioxidants have captured significant interest for decades due to their potential role in preventing chronic diseases. These molecules combat free radicals and unstable molecules that damage cells and contribute to the development of conditions like metabolic diseases, heart disease, cancer, and neurodegenerative diseases. This thematic issue will explore the cutting-edge ...read more
Bioactive Compounds: An Ideal Source for Drug Discovery, Design, Development and _target Identification
The Special Issue "Bioactive Compounds: Discovery, Design, Development, and _target Identification" aims to bring together innovative research and critical reviews on bioactive molecules that show therapeutic potential across diverse diseases. Discovery of novel bioactive compounds will focus on uncovering new molecules from natural or synthetic sources, expanding the library of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Pathophysiology of CTGs and Types of Intrapartum Hypoxia
Current Women`s Health Reviews RAAS Inhibition and Renal Protection
Current Pharmaceutical Design Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia
Current Drug _targets Stroke and Hypertension: An Appraisal from Pathophysiology to Clinical Practice
Current Vascular Pharmacology Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism New Drugs for Epidural Analgesia
Current Drug _targets Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications
Current Drug Delivery Cardiovascular Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Hairy Roots, their Multiple Applications and Recent Patents
Recent Patents on Biotechnology Enhanced Anticancer Activity and Apoptosis Effect of Bioactive Compound Quercetin Extracted from <i>Ocimum sanctum</i> Leaves
Current Nanomedicine Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-_targeted Antioxidants
Infectious Disorders - Drug _targets Carotid Baroreceptor Stimulation: A Promising Approach for the Management of Resistant Hypertension and Heart Failure
Current Vascular Pharmacology The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry _targets and Tools: Recent Advances in the Development of Anti-HCV Nucleic Acids
Infectious Disorders - Drug _targets The Epidemiology of Sepsis
Current Pharmaceutical Design Opioid-Free Anaesthesia Improves Anaesthesia Recovery when Compared with that of Opioid-Based Anaesthesia. Systematic Review and Meta-Analysis of Clinical Trials
Current Medicinal Chemistry The Promises and Challenges of the Use of Genomics in the Prescription of Exercise for Hypertension: The 2013 Update
Current Hypertension Reviews Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications
Current Vascular Pharmacology Characterization of a Novel ADPase in Bothrops jararaca Snake Venom Involved in Nucleotide Hydrolysis
Protein & Peptide Letters